Abstract
Sublingual immunotherapy (SLIT) plays an important role in the treatment of bronchial asthma(asthma) and allergic rhinitis, it is accepted as an alternative to the traditional subcutaneous immunotherapy. Sublingual liquid drops or sublingual tablets have been used in SLIT. The results from clinical study provides evidence that SLIT is clinically effective and safe in the treatment of asthma and allergic rhinitis. Key words: Sublingual immunotherapy; Asthma; Allergic rhinitis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
